Drug Channels
Pages
(Move to ...)
ABOUT
INDUSTRY REPORTS
WEBINARS
ADVERTISE
SUBSCRIBE / CONTACT
▼
Friday, May 31, 2024
Shifting Strategies: Tackling Patient Support Program Reverification
›
Today’s guest post comes from Jan Nielsen, Patient Solutions Division President at AssistRx. Jan discusses the challenges facing life s...
Wednesday, May 29, 2024
Drug Channels News Roundup, May 2024: CVS & Cordavis & Humira, 340Boom, AFP Slowdown, Asembia Wrap-Up, and GLP-1 Humor
›
Summer unofficially began over the weekend. Let’s turn up the heat with these sizzling news bites, seared to perfection on the Drug Channels...
Wednesday, May 22, 2024
Why the IRA Will Encourage Part D Plans to Prefer High-List, High-Rebate Drugs (video)
›
In my recent Drug Channel Implications of the Inflation Reduction Act video webinar, I explained the intended and unintended consequences o...
Tuesday, May 21, 2024
The 340B Drug Pricing Program: Trends, Controversies, and Outlook (NEW Live Video Webinar)
›
Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live vi...
Friday, May 17, 2024
HCP Perspectives: Access Challenges in Treating Diabetes & Obesity
›
Today’s guest post is from Dr. Preeti Parikh, a practicing pediatrician and VP, Executive Medical Director at GoodRx. At the recent Publici...
Tuesday, May 14, 2024
Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs
›
Contrary to what you may have heard, the Inflation Reduction Act’s (IRA) inflation rebates for Medicare Part B drugs do not always save mone...
Friday, May 10, 2024
Solving Access Barriers in Biomarker Testing: 5 Tips for Manufacturers
›
Today’s guest post comes from Hannah Baxter, Associate Partner at The Dedham Group; Jen Klarer, Partner, Head of Cell & Gene Therapy at...
Tuesday, May 07, 2024
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update
›
It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and providers within U.S...
Friday, May 03, 2024
Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act
›
Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris explains how the Inflation Reduction Act...
Tuesday, April 30, 2024
Drug Channels News Roundup, April 2024: CVS’s Humira Strategy, White Bagging “Savings,” IRA vs. Part D Plans, Walgreens Specialty Update, Pharmacies vs. GoodRx, and Oncology Fun
›
April is over, so it's time to hop into this month’s selection of noteworthy news: CVS Health’s formulary boosts a Humira biosimilar ...
Friday, April 26, 2024
Breaking Down Barriers: Helping Patients Get Therapies Quickly
›
Today’s guest post comes from Kevin Kettler, President of CoverMyMeds. Kevin asks: What if there were no barriers across the therapy acces...
Wednesday, April 24, 2024
Independents Outshine PBMs in Manufacturers’ Exclusive Specialty Pharmacy Networks
›
Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 Specialty Pharmacies of 20...
‹
›
Home
View web version